Naknarin Suchada

Naknarin Suchada

Auto-generated profile, based on publicly available information

Naknarin Suchada


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
NSNaknarin Suchada
Naknarin Suchada
AIArunporn Itharat
Arunporn Itharat
Rawiwan WongpoomchaiRawiwan Wongpoomchai
Rawiwan Wongpoomchai
PSPanthong Sumalee
Panthong Sumalee
Weerachai PipatrattanasereeWeerachai Pipatrattanaseree
Weerachai Pipatrattanaseree
CMChatchai Mingmalairak
Chatchai Mingmalairak
Context: Saban remedy is used at Khampramong Temple to relieve adverse effects in liver cancer patients. Aims: To analyze the taste and biological activities of Saban remedy and Cassia garrettiana as a principal component species in liver cancer treatment supported in vitro and in vivo. Methods: Saban remedy and its ingredient extracts were tested for cytotoxic activity against hepatocellular carcinoma (HepG2, KKU-M156), cholangiocarcinoma cells, and normal human lung fibroblast cells (MRC-5) using the sulforhodamine B assay. Anti-inflammatory effects were evaluated through inhibition of inflammatory cytokine production (RAW 264.7 cell line), and mutagenicity and anti-mutagenicity were assessed using the Salmonella typhimurium strain TA98 and TA100 mutation assay. Both Saban remedy extracts and ethanolic C. garrettiana extract were tested in vivo for anti-hepatocarcinogenesis during the initiation stage in male Wistar rats. Results: Saban remedy, traditionally used as a purgative, exhibited bitter and bitter-nauseating flavors. The remedy demonstrated in vitro cytotoxic activity and in vivo reduction of GST-P foci in liver tissue, indicating protective and therapeutic potential against liver cancer. Saban remedy ethanolic extracts showed significant anti-inflammatory effects through nitric oxide inhibition. Notably, the aqueous extract of Saban remedy effectively reduced GST-P foci, a preneoplastic liver lesion, though it exhibited fewer biological activities compared to the ethanolic extract. This aligns with Khampramong Temple’s clinical use of the aqueous solution in cancer patients. Conclusions: The taste and biological properties of Saban remedy are correlated, supporting its use in treating liver cancer through various bioactivities.